In 2011 Simo Jääskeläinen was Medaffcon’s first recruitment. A couple of years ago Simo spread his wings to tackle new challenges and further develop his experience in different Market Access positions.
Simo has more than 12 years of experience from the pharmaceutical industry.
Now in June, to our great joy, Simo returned to Medaffcon, taking on the responsibility of leading our Market Access team. We are glad to welcome Simo back “home”!
At Medaffcon, this experience from the pharmaceutical and medtech industries, already exceeds 130 working years, all of which is harnessed to find the best solutions for our customers. Due to our experience and over 400 Medaffcon projects, we understand our customers’ playing field probably better than any of our competitors!
The reform of the Secondary Use Act will establish a new decentralised process, in parallel to the current centralised permit model in which Findata grants all data permits.
As we approach the end of 2025 and prepare to slow down for the holidays, I want to take a moment to reflect on an exceptional year for Medaffcon—one defined by growth and expansion.
The conference explores how real-world data (RWD) and artificial intelligence (AI) can transform drug development, regulatory and HTA decision-making, and ultimately drive value-based, patient-focused healthcare.